Pear Therapeutics, Inc.: current_assets
| Value | {"amount": 126057000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Pear Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e2eba57b-c3bc-47d0-b372-e068477ca14b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001835567-22-000010 · Open the official SEC filing →Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001835567/current-assets/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e2eba57b-c3bc-47d0-b372-e068477ca14b
History
- supersedes {"amount": 0, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} (evidence 0001193125-21-320588)